(:CMD)

May 06, 2021 11:04 am ET
Mar Cor Launches Its Newest and Most Advanced Portable Reverse Osmosis Water System
Mar Cor Purification, Inc., a Cantel Medical Corp. (NYSE: CMD) business, announces the launch of the EON™ Portable Dialysis Water System. The portable water purification device uses reverse osmosis (RO) to remove organic and inorganic substances and microbial contaminants from water that feeds into hemodialysis machines to treat hemodialysis patie
Mar 11, 2021 10:00 pm ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Buyout Investigation
Rigrodsky Law, P.A. announces that it is investigating: Cubic Corporation (NYSE: CUB) regarding possible breaches of fiduciary duties and other violations of law related to Cubic’s agreement to be acquired by affiliates of Veritas Capital and...
Mar 02, 2021 05:48 pm ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Buyouts
Rigrodsky Law, P.A. announces that it is investigating: CoreLogic, Inc. (NYSE: CLGX) regarding possible breaches of fiduciary duties and other violations of law related to CoreLogic’s agreement to be acquired by affiliates of Stone Point Capital...
Feb 25, 2021 04:46 pm ET
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - CUB, COHR, CMD, FLIR, BPFH, AJRD
NEW YORK, Feb. 25, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Feb 25, 2021 12:11 pm ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2021
LITTLE FALLS, N.J., Feb. 25, 2021 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2021 on Tuesday, March 9, 2021 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
Feb 24, 2021 09:58 am ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Buyout Investigation
Rigrodsky Law, P.A. announces that it is investigating: Perspecta Inc (NYSE: PRSP) regarding possible breaches of fiduciary duties and other violations of law related to Persepcta’s agreement to be acquired by affiliates of Peraton. Under the...
Feb 18, 2021 08:00 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates BPFH, CMD, PRGX, HMSY; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Boston Private Financial Holdings, Inc. (NASDAQ: BPFH) concerning potential violations of the federal securities laws and/or breaches of...
Feb 12, 2021 10:53 am ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of VIE, FFG, COHR, and CMD Buyouts
Rigrodsky Law, P.A. announces that it is investigating: Viela Bio, Inc. (NASDAQ GS: VIE) regarding possible breaches of fiduciary duties and other violations of law related to Viela Bio’s agreement to be acquired by Horizon Therapeutics plc. Under...
Feb 12, 2021 05:20 am ET
Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - MGLN, BPFH, CMD, GWPH, SPWH, ALSK
NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:
Feb 09, 2021 08:35 pm ET
INVESTIGATION ALERT: Halper Sadeh LLP Investigates FFG, CMD, TCP, MDCA; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: FBL Financial Group, Inc. (NYSE: FFG) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties...
Feb 09, 2021 02:37 pm ET
CANTEL MEDICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD
NEW ORLEANS, Feb. 9, 2021 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE).  Under the terms of the proposed transaction, shareholders of Cantel will receive only $16.93 in cash and 0.33787 of a STERIS ordinary share for each share of Cantel that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Feb 04, 2021 04:59 am ET
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - TCF, BPFH, CMD, HMSY
NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Jan 30, 2021 03:39 pm ET
Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm – CMD, PRSP, NAV, FLIR
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to...
Jan 29, 2021 09:00 pm ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigations of BPFH, FFG, CHNG, and CMD Buyouts
Rigrodsky Law, P.A. announces that it is investigating: Boston Private Financial Holdings, Inc. (NASDAQ GS: BPFH) regarding possible breaches of fiduciary duties and other violations of law related to Boston Private’s agreement to be acquired by...
Jan 28, 2021 01:50 pm ET
INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders - PRSP, CMD, WDR, SPWH, WTRE
NEW YORK, Jan. 28, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Jan 21, 2021 03:09 pm ET
MERGER INVESTIGATION: Halper Sadeh LLP Investigates CMD, COHR, PS, OXFD; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating...
Jan 20, 2021 11:15 am ET
INVESTIGATION ALERT: Halper Sadeh LLP Investigates FLIR, SMTX, NHLD, FFG, CMD; Shareholders Are Encouraged to Contact the Firm
NEW YORK, Jan. 20, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Jan 14, 2021 01:15 pm ET
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CMD, INFO, PS, TCF; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cantel Medical Corp. (NYSE: CMD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties...
Jan 13, 2021 07:30 pm ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Cantel Medical Corp. Buyout
Rigrodsky Law, P.A. announces that it is investigating Cantel Medical Corp. (“Cantel”) (NYSE: CMD) regarding possible breaches of fiduciary duties and other violations of law related to Cantel’s agreement to be acquired by STERIS plc (“STERIS”)...
Jan 13, 2021 07:27 pm ET
CANTEL MEDICAL INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE). Under the terms of the proposed transaction, shareholders of Cantel will receive only $16.93 in cash and 0.33787 of a STERIS ordinary share for each share of Cantel that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Jan 13, 2021 01:59 pm ET
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Cantel Medical Corp. - CMD
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cantel Medical Corp. ("CMD" or the "Company") (CMD) relating to its proposed acquisition by STERIS plc. Under the terms of the agreement, CMD shareholders will receive $16.93 in cash and 0.33787 shares of STERIS stock per share they own.
Jan 13, 2021 03:40 am ET
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates CMD, TCF, ALSK, SMTX, ZAGG; Shareholders Are Encouraged to Contact the Firm
NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Jan 12, 2021 04:06 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Investigates Cantel Medical Corp.
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Cantel Medical Corp. ("CMD" or the "Company") (NYSE: CMD) in connection with the proposed acquisition of the Company by STERIS plc ("STERIS") (NYSE: STE).  Under the terms of the merger agreement, STERIS will acquire CMD in a mixed cash-and-stock transaction, pursuant to which CMD shareholders will receive $16.93 in cash and 0.33787 of a STERIS ordinary share for each CMD share that they own, representing implied per-share merger c
Jan 12, 2021 12:29 pm ET
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Cantel Medical Corporation
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Cantel Medical Corporation (NYSE: CMD) ("Cantel") and its board of directors concerning the proposed acquisition of the company by Steris Plc (NYSE: STE) ("Steris"). Under the terms of the agreement, Cantel common stockholders will receive approximately $16.93 in cash and 0.33787 of a Steris ordinary share, or a total of value of approximately $84.66 per Cantel common share based on Steris's closing share price of $200.46 on January 11, 2021. The transaction is valued at approximat
Jan 12, 2021 12:21 pm ET
CANTEL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CMD and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Cantel Medical Corp. (NYSE: CMD) breached their fiduciary duties or violated the federal securities...
Jan 12, 2021 09:48 am ET
Cantel Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Cantel Medical Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CMD
Halper Sadeh LLP, a global investor rights law firm, is investigating whether Cantel Medical Corp. (NYSE: CMD) and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the proposed sale of Cantel to STERIS plc. Under the terms of the merger agreement, Cantel shareholders will receive approximately $16.93 in cash and 0.33787 of a STERIS ordinary share per Cantel common share.
Jan 12, 2021 07:12 am ET
STERIS Announces Definitive Agreement to Acquire Cantel Medical
STERIS plc (NYSE: STE) (“STERIS” or the “Company”) and Cantel Medical Corp (NYSE:CMD) (“Cantel”) today announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary.  Cantel is a global provider of infection...
Dec 08, 2020 06:00 am ET
Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2021
LITTLE FALLS, N.J., Dec. 8, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2020.
Dec 07, 2020 10:00 am ET
Cantel Medical and Censis Technologies Enter into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution
LITTLE FALLS, N.J., Dec. 7, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) and Censis Technologies announced today a new long-term partnership to combine Cantel's leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.
Dec 03, 2020 08:00 am ET
Cantel Announces Senior Leadership Promotions in Dental
LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021. He will be taking over for Ken Serota, who will be stepping down as President effective December 31, 2020. In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel. Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Lea
Nov 24, 2020 06:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2020
LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
Oct 22, 2020 07:00 am ET
Cantel Pre-Announces Estimated Revenue for the 1st Quarter
LITTLE FALLS, N.J., Oct. 22, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced an estimated revenue range for the company's first fiscal quarter, ending on October 31st, 2020, of $290 - $295 million, an increase of approximately 25% sequentially from the prior quarter, a year over year increase of  approximately 14% on a reported basis and a decrease of approximately 3% on an organic basis.
Aug 06, 2020 07:00 am ET
Cantel Pre-Announces Estimated Revenue for the 4th Quarter
LITTLE FALLS, N.J., Aug. 6, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced an estimated revenue range for the company's fiscal fourth quarter, which ended July 31st, 2020. Revenue for the fourth quarter is estimated at $230 - $235 million, a decrease of approximately 2% sequentially vs. the prior quarter, and down approximately 19% vs. the prior year on an organic basis.
Aug 03, 2020 07:00 am ET
Cantel Promotes Peter Clifford to President
LITTLE FALLS, N.J., Aug. 3, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that Peter Clifford, currently Executive Vice President and Chief Operating Officer, has been promoted to President and Chief Operating Officer. Mr. Clifford will continue to report to George Fotiades, Chief Executive Officer, and be based in Little Falls, NJ.
Jun 04, 2020 07:00 am ET
Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2020
LITTLE FALLS, N.J., June 4, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2020.
May 22, 2020 01:00 pm ET
Cantel Announces Full Exercise of Option by Initial Purchasers to Purchase Additional Convertible Senior Notes
LITTLE FALLS, N.J., May 22, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) ("Cantel" or the "Company") today announced the sale of $28 million in aggregate principal amount of its 3.25% convertible senior notes due 2025 in respect of the Company's previously announced private offering of the notes to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), pursuant to the full exercise by the initial purchasers of their option to purchase additional notes. The Company has issued a total o
May 21, 2020 07:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Third Quarter Ended April 30, 2020
LITTLE FALLS, N.J., May 21, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its third quarter ended April 30, 2020 on Thursday, June 4, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
May 13, 2020 07:38 am ET
Cantel Announces Pricing of $140 Million Private Offering of Convertible Senior Notes Due 2025
LITTLE FALLS, N.J., May 13, 2020     /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) ("Cantel" or the "Company") today announced the pricing of its offering of $140 million aggregate principal amount of 3.25% convertible senior notes due 2025 (the "Notes") in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company also granted the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days from, and including, the dat
May 12, 2020 07:31 am ET
Cantel Announces Proposed Private Offering of Convertible Senior Notes Due 2025
LITTLE FALLS, N.J., May 12, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) ("Cantel" or the "Company") today announced its intention to offer, subject to market and other conditions, $150 million aggregate principal amount of convertible senior notes due 2025 (the "Notes") in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Company also intends to grant the initial purchasers of the Notes an option to purchase up to an additional $22.5 million aggre
May 12, 2020 07:30 am ET
Cantel Announces Amended Credit Facility; Provides Update on COVID Impact
LITTLE FALLS, N.J., May 12, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today several business and financial updates in light of the ongoing COVID pandemic.
Apr 01, 2020 11:00 am ET
Cantel Announces Initiatives to Help Fight COVID-19
LITTLE FALLS, N.J., April 1, 2020 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today specific areas of focus and associated actions to combat the COVID-19 virus. In these unprecedented times, the company is concentrating on enhanced production, product innovation and value-add COVID-19 education in support of first-responders and other healthcare professionals.
Oct 28, 2019 06:53 pm ET
Cantel Appoints Karen Prange to Board of Directors
LITTLE FALLS, N.J., Oct. 28, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD), announced today the appointment of Karen Prange to the Company's Board of Directors, bringing to the Board more than 25 years of healthcare and life sciences leadership experience. Most recently, Ms. Prange was Executive Vice President and Chief Executive Officer of the Global Animal Health, Medical and Dental Surgical Group at Henry Schein.
Oct 02, 2019 07:30 am ET
Cantel Completes Acquisition of Hu-Friedy
LITTLE FALLS, N.J., Oct. 2, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that it has completed its previously announced acquisition of Hu-Friedy Mfg. Co LLC, a 111-year-old global leading manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. The purchase price payable at closing for the acquisition consisted of 751,471 shares of Cantel common stock and $665 million in cash, subject to customary adjustments. As previously disclosed, the transaction structure is anticipated to result in tax benefits to Cantel presently va
Sep 23, 2019 07:00 am ET
Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2019
LITTLE FALLS, N.J., Sept. 23, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2019.
Sep 12, 2019 10:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter Ended July 31, 2019
LITTLE FALLS, N.J., Sept. 12, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its fourth quarter ended July 31, 2019 on Monday, September 23, 2019 before the market opens, and hold a conference call to discuss the results at 8:30 a.m. ET.
Aug 15, 2019 12:25 pm ET
Cantel Recognized by 2020 Women on Boards for Gender Diversity
LITTLE FALLS, N.J., Aug. 15, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) has been named a Winning 'W' Company by 2020 Women on Boards (2020WOB) for having women make up at least 20% of its Board of Directors.
Jul 30, 2019 07:00 am ET
Cantel to Acquire Hu-Friedy
LITTLE FALLS, N.J. and CHICAGO, July 30, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE:CMD) ("Cantel" or the "Company"), a global leader in instrument reprocessing and innovative infection prevention products and services, today announced that it has entered into a definitive agreement to acquire privately-held Hu-Friedy Mfg. Co. ("Hu-Friedy"), a 111-year-old global leading manufacturer of instruments and instrument reprocessing workflow systems serving the dental industry. This combination creates a provider of comprehensive infection prevention, instrument and instrument management solut
Jul 10, 2019 11:34 am ET
Cantel Announces Retirement of Eric Nodiff, General Counsel; Jeff Mann Named Successor
LITTLE FALLS, N.J., July 10, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that Eric Nodiff, Executive Vice President, General Counsel and Secretary, will be retiring on July 31, 2019 after 32 years of service to the Company and Jeff Mann has been appointed as Senior Vice President, General Counsel and Secretary, effective August 1, 2019.
May 23, 2019 08:00 am ET
Cantel Medical to Present at the Jefferies 2019 Global Healthcare Conference
LITTLE FALLS, N.J., May 23, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Peter Clifford, Executive Vice President and Chief Operating Officer, will be presenting at the Jefferies 2019 Global Healthcare Conference at the Grand Hyatt, New York. The formal presentation is scheduled for Friday, June 7, 2019 at 1:00 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
May 13, 2019 08:00 am ET
Cantel Promotes Peter Clifford to Chief Operating Officer and Appoints Shaun Blakeman as Chief Financial Officer
LITTLE FALLS, N.J., May 13, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that Peter Clifford has been promoted to Executive Vice President and Chief Operating Officer. As part of this change in leadership, Shaun Blakeman has been appointed as Senior Vice President and Chief Financial Officer. Mr. Clifford and Mr. Blakeman will be located in Little Falls, N.J. and will serve on the Executive Leadership Team.
Apr 17, 2019 07:20 am ET
Market Trends Toward New Normal in Zymeworks, Pro-Dex, Cantel Medical, Vaalco Energy, Perion Network, and Atlas Financial — Emerging Consolidated Expectations, Analyst Ratings
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Zymeworks Inc. (NYSE:ZYME), Pro-Dex, Inc. (NASDAQ:PDEX), Cantel Medical...
Apr 02, 2019 08:00 am ET
Cantel Medical to Present at the 18th Annual Needham Healthcare Conference
LITTLE FALLS, N.J., April 2, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that George Fotiades, President and CEO, will be presenting at the 18th Annual Needham Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 10, 2019 at 2:50 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
Mar 18, 2019 08:00 am ET
Cantel Appoints Jean Casner to Senior Vice President and Chief Human Resources Officer
LITTLE FALLS, N.J., March 18, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jean Casner has recently been appointed to Senior Vice President and Chief Human Resources Officer. Ms. Casner will serve on the Executive Leadership Team and report to George Fotiades, President and CEO. 
Mar 05, 2019 08:00 am ET
Cantel Medical Names George L. Fotiades President and CEO
LITTLE FALLS, N.J., March 5, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced that George L. Fotiades has been named the Company's President and Chief Executive Officer, effective immediately.  Mr. Fotiades also will continue to serve on Cantel's Board of Directors.  He succeeds Jorgen B. Hansen, who has resigned from the Company and its Board of Directors.  
Feb 28, 2019 07:00 am ET
Cantel Medical Reports Financial Results for its Second Quarter Fiscal Year 2019
LITTLE FALLS, N.J., Feb. 28, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2019.
Feb 22, 2019 11:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2019
LITTLE FALLS, N.J., Feb. 22, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its second quarter ended January 31, 2019 on Thursday, February 28, 2019 before the market opens, and hold a conference call to discuss the results at 9:30 a.m. ET.
Feb 01, 2019 08:21 am ET
Cantel Completes Acquisition of Omnia S.p.A.
LITTLE FALLS, N.J., Feb. 1, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that it has completed its previously announced acquisition of Omnia S.p.A. ("Omnia"), an Italian-based market leader in dental surgical consumables solutions.
Jan 11, 2019 07:00 am ET
Cantel Acquires Vista Research Group
LITTLE FALLS, N.J., Jan. 11, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that it has acquired Vista Research Group, LLC. ("Vista Research Group"), a company that provides a complete line of innovative water treatment, purification and management solutions for the dental industry. The total purchase price was approximately $10.5 million in cash consideration, consisting of $7 million in an upfront payment and $3.5 million in an earnout payment based on the achievement of certain performance-based targets over a two-year period. Total sales of Vista Research Group in 2
Jan 03, 2019 10:08 am ET
Cantel Medical to Present at the 21st Annual Needham Growth Conference
LITTLE FALLS, N.J., Jan. 3, 2019 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Peter Clifford, Executive Vice President and CFO, will be presenting at the 21st Annual Needham Growth Conference at the Lotte New York Palace Hotel in New York. The formal presentation is scheduled for Wednesday, January 16, 2019 at 3:30 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
Dec 21, 2018 07:00 am ET
Cantel Medical to Present at the 37th Annual J.P. Morgan Healthcare Conference
LITTLE FALLS, N.J., Dec. 21, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 37th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. The formal presentation is scheduled for Tuesday, January 8, 2019 at 5:00 p.m. PT. In addition, management will be available for separate one-on-one meetings during the day.
Dec 19, 2018 09:34 am ET
Cantel Medical Announces 17.6% Increase In Semiannual Dividend
LITTLE FALLS, N.J., Dec. 19, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.085 to $0.10 per outstanding share of the Company's Common Stock. The dividend is payable on January 31, 2019 to shareholders of record at the close of business on January 17, 2019.
Nov 29, 2018 07:00 am ET
Cantel Medical Reports Financial Results for its First Quarter Fiscal Year 2019
LITTLE FALLS, N.J., Nov. 29, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2018.
Nov 23, 2018 07:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2018
LITTLE FALLS, N.J., Nov. 23, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its first quarter ended October 31, 2018 on Thursday, November 29, 2018 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. ET. 
Nov 14, 2018 08:00 am ET
New Research Coverage Highlights Nexa Resources S.A, Qumu, Clearway Energy, Vermillion, Cantel Medical, and Theravance Biopharma — Consolidated Revenues, Company Growth, and Expectations for 2018
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Nexa Resources S.A. (NYSE:NEXA), Qumu Corporation (NASDAQ:QUMU), Clearway...
Nov 12, 2018 08:28 am ET
Cantel to Acquire Omnia S.p.A
LITTLE FALLS, N.J., Nov. 12, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD), announced today that it has entered into a definitive agreement to purchase Omnia S.p.A. ("Omnia"), an Italian-based market leader in dental surgical consumables solutions. 
Nov 01, 2018 09:00 am ET
Cantel Appoints Bill Haydon to Senior Vice President and General Manager of Medical Division
LITTLE FALLS, N.J., Nov. 1, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that Bill Haydon has been recently appointed to Senior Vice President and General Manager of the Medical division. Mr. Haydon will serve on the Executive Leadership Team and report to Jorgen B. Hansen, President and CEO.
Sep 27, 2018 08:00 am ET
Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2018
LITTLE FALLS, N.J., Sept. 27, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2018.
Sep 20, 2018 08:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter and Year Ended July 31, 2018
LITTLE FALLS, N.J., Sept. 20, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its fourth quarter ended July 31, 2018 on Thursday, September 27, 2018 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. Eastern Daylight Time. In addition, during the conference call, the Company will provide financial guidance with respect to the full fiscal year ending July 31, 2019.
Sep 05, 2018 08:00 am ET
Cantel Announces Plans to Expand to New Facility in Minnesota
LITTLE FALLS, N.J., Sept. 5, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions, announced today that it has recently purchased a new office building at 9800 59th Ave. N. in Plymouth, Minnesota that has capacity for approximately 600 employees.  The company is consolidating four of its locations into a single four-story, 159,000-square-foot building.   
Aug 28, 2018 08:00 am ET
Cantel Medical to Present at the Raymond James 14th Annual North American Equities Conference in London, England
LITTLE FALLS, N.J., Aug. 28, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that Peter Clifford, Executive Vice President and CFO, will be presenting at the Raymond James 14th Annual North American Equities Conference at the Four Seasons London at Park Lane in London, England. The formal presentation is scheduled for Tuesday, September 11, 2018 at 1:10 p.m. GMT +1 (8:10 a.m. ET/5:10 a.m. PT). In addition, management will be available for separate one-on-one meetings during the day.
Aug 03, 2018 08:00 am ET
Cantel Expands its Life Sciences Portfolio through Acquisition of Stericycle's Controlled Environmental Solutions Business
LITTLE FALLS, N.J., Aug. 3, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD), announced today that it has acquired Stericyle, Inc.'s (Nasdaq: SRCL) Controlled Environmental Solutions business ("CES business") for a cash purchase price of $17.0 million on a cash-free and debt-free basis. The CES business, consisting of B&V Testing and Certco services, is a leading provider of testing and certification, environmental monitoring and decontamination services for clean rooms and other controlled environments to ensure safety, regulatory compliance and quality control.  
Jul 02, 2018 08:30 am ET
Cantel Medical Announces Completion of Credit Agreement Refinancing
LITTLE FALLS, N.J., July 2, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced that it has completed a refinancing of its credit facility by amending the existing agreement to include a $200 million of tranche A term loan and a $400 million revolving credit facility. A portion of the proceeds of the new tranche A term loan were used by Cantel to repay $164 million of revolving credit loans under the existing credit agreement and to pay transaction fees and expenses. Future borrowings under the amended revolving credit facility will be used to support Cantel's strategic gro
Jun 27, 2018 09:07 am ET
Cantel Medical Board of Directors Authorizes Regular Semiannual Dividend
LITTLE FALLS, N.J., June 27, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced that its Board of Directors authorized a regular semiannual cash dividend of $0.085 per outstanding share of the Company's Common Stock. The dividend is payable on July 31, 2018 to shareholders of record at the close of business on July 17, 2018.
Jun 18, 2018 09:00 am ET
Cantel Expands its Dental Water Solutions Portfolio with Entry into Amalgam Separator Category
LITTLE FALLS, N.J., June 18, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced its entry into the dental wastewater management market through the recent launch of Syclone™ Amalgam Separator, previously marketed and sold under the brand name, Apavia™ Amalgam Separator. This new filtration technology and related assets were recently acquired from ENPRESS L.L.C. and its subsidiary Apavia LLC.
May 31, 2018 08:00 am ET
Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2018
LITTLE FALLS, N.J., May 31, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2018.
May 24, 2018 08:30 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Third Quarter Ended April 30, 2018
LITTLE FALLS, N.J., May 24, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its third quarter ended April 30, 2018 on Thursday, May 31, 2018 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. Eastern Daylight Time.
May 23, 2018 10:00 am ET
Cantel Medical to Present at the Jefferies 2018 Global Healthcare Conference
LITTLE FALLS, N.J., May 23, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jorgen Hansen, President and Chief Executive Officer, will be presenting at the Jefferies 2018 Global Healthcare Conference at the Grand Hyatt in New York City. The formal presentation is scheduled for Tuesday, June 5, 2018 at 2:30 p.m. EDT. In addition, management will be available for separate one-on-one meetings during the day.
Apr 18, 2018 09:00 am ET
Cantel Medical Receives FDA 510(k) Clearance to Market ADVANTAGE PLUS® Pass-Thru Automated Endoscope Reprocessor
LITTLE FALLS, N.J., April 18, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that it has received U.S. Food and Drug Administration (FDA) 510 (k) clearance for its ADVANTAGE PLUS® Pass-Thru automated endoscope reprocessor (AER).
Mar 21, 2018 08:30 am ET
Cantel Medical Acquires Aexis Medical
Acquisition further advances global leadership position in infection prevention through entry into healthcare information analytics market
Mar 21, 2018 08:30 am ET
Cantel Medical Acquires Aexis Medical
Acquisition further advances global leadership position in infection prevention through entry into healthcare information analytics market
Mar 19, 2018 11:03 am ET
Cantel Medical to Participate in Fireside Chat at the 17th Annual Needham & Company Healthcare Conference
LITTLE FALLS, N.J., March 19, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jorgen B. Hansen, President and CEO, will be participating in an analyst-led fireside chat with investors at the 17th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York, on Tuesday, March 27 at 4:30 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
Mar 09, 2018 04:54 pm ET
Take-Two Interactive Software, SVB Financial and Nektar Pharmaceuticals Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
NEW YORK, March 9, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective prior to the open on Monday, March 19 to coincide with the March rebalance. All companies moving to the S&P 500 have total market capitalizations above $12 billion. All companies moving to the S&P MidCap 400 and S&P SmallCap 600 are more appropriate for those indices.
Mar 08, 2018 07:00 am ET
Cantel Medical Reports Record Financial Results for its Second Quarter Fiscal Year 2018
LITTLE FALLS, N.J., March 8, 2018 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2018.
Mar 01, 2018 07:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2018
LITTLE FALLS, N.J., March 1, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its second quarter ended January 31, 2018 on Thursday, March 8, 2018 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. Eastern Standard Time. In addition, during the conference call, the Company will provide financial guidance with respect to the full fiscal year 2018 along with the expected full year effective tax rate.
Feb 14, 2018 07:00 am ET
Cantel Medical Promotes Lawrence Conway to Senior Vice President, Business Systems and Integration
LITTLE FALLS, N.J., Feb. 14, 2018 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Lawrence Conway has been recently appointed to Senior Vice President, Business Systems and Integration. In this role, Mr. Conway will be responsible for the integration of Cantel's acquisitions along with his current role of leading the business systems function.
Dec 28, 2017 11:29 am ET
Cantel Medical to Present at the 36th Annual J.P. Morgan Healthcare Conference
LITTLE FALLS, N.J., Dec. 28, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 36th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. The formal presentation is scheduled for Wednesday, January 10, 2018 at 11:00 a.m. PT. In addition, management will be available for separate one-on-one meetings during the day.
Dec 07, 2017 08:00 am ET
Cantel Medical Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / December 7, 2017 / Cantel Medical Corp. (NYSE: CMD) will be discussing their earnings results in their Q1 Earnings Call to be held on December 7, 2017 at 11:00 AM Eastern Time.
Dec 07, 2017 07:00 am ET
Cantel Medical Reports Record Financial Results for its First Quarter Fiscal Year 2018
LITTLE FALLS, N.J., Dec. 7, 2017 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its first quarter ended October 31, 2017.
Dec 06, 2017 04:10 pm ET
Investor Network Invites You to the Cantel Medical Corp. First Quarter 2018 Earnings Conference Call and Webcast Live on Thursday, December 7, 2017
LITTLE FALLS, NJ / ACCESSWIRE / December 6, 2017 / Cantel Medical Corp. (NYSE: CMD) will host a conference call and live webcast to discuss the results of the first quarter 2017, to be held Thursday, December 7, 2017 at 11:00 AM Eastern Time.
Nov 30, 2017 07:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2017
LITTLE FALLS, N.J., Nov. 30, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its first quarter ended October 31, 2017 on Thursday, December 7, 2017 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. Eastern Time.
Nov 02, 2017 09:00 am ET
Cantel Medical to Present at the Jefferies 2017 London Healthcare Conference
LITTLE FALLS, N.J., Nov. 2, 2017 /PRNewswire/ -- Cantel Medical Corp. (NYSE:CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the Jefferies 2017 London Healthcare Conference at the Waldorf Hilton, London, UK. The formal presentation is scheduled for Wednesday, November 15, 2017 at 8:00 a.m. GMT +1 (3:00 a.m. ET/12:00 a.m. PT). In addition, management will be available for separate one-on-one meetings during the day.
Nov 01, 2017 12:17 pm ET
Cantel Medical Announces 21% Increase In Semiannual Dividend
LITTLE FALLS, N.J., Nov. 1, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.07 to $0.085 per outstanding share of the Company's Common Stock. The dividend is payable on January 31, 2018 to shareholders of record at the close of business on January 17, 2018.
Sep 28, 2017 09:00 am ET
Cantel Medical Reports Record Financial Results For The Fourth Quarter Ended July 31, 2017
LITTLE FALLS, N.J., Sept. 28, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) reported net income of $16,997, or $0.41 per diluted share, on a 14.8% increase in net sales to $205,502 for the fourth quarter ended July 31, 2017. This compares with net income of $16,291, or $0.39 per diluted share, on net sales of $179,002 for the fourth quarter ended July 31, 2016. For the full fiscal year ended July 31, 2017, the Company reported net income of $71,378, or $1.71 per diluted share, on a 15.9% increase in net sales to a record $770,157. This compares with net income of $59,953, or $1.44 pe
Sep 21, 2017 09:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Fourth Quarter and Fiscal Year Ended July 31, 2017
LITTLE FALLS, N.J., Sept. 21, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its fourth quarter and fiscal year ended July 31, 2017 on Thursday, September 28 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. Eastern Time. In addition, during the conference call, the Company will provide financial guidance with respect to the full fiscal year ending July 31, 2018.
Aug 23, 2017 09:49 am ET
Cantel Medical Completes Acquisition of BHT Group in Germany
LITTLE FALLS, N.J., Aug. 23, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that it has completed its previously announced acquisition of BHT Hygienetechnik Holding GmbH ("BHT Group"), the German market leader in automated endoscope reprocessing and related equipment and services as well as flexible endoscope repair.
Jul 31, 2017 09:00 am ET
Cantel Medical to Acquire BHT Group in Germany
LITTLE FALLS, N.J., July 31, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions, announced today that it entered into a definitive agreement to purchase BHT Hygienetechnik Holding GmbH ("BHT Group"), the German market leader in automated endoscope reprocessing and related equipment and services and flexible endoscope repair, for a cash purchase price of approximately $60.8 million on a cash-free and debt- free basis.
Jun 29, 2017 10:44 am ET
Cantel Medical Board of Directors Authorizes Regular Semiannual Dividend
LITTLE FALLS, N.J., June 29, 2017 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced that its Board of Directors authorized a regular semiannual cash dividend of $0.07 per outstanding share of the Company's Common Stock. The dividend is payable on July 31, 2017 to shareholders of record at the close of business on July 17, 2017.
Jun 08, 2017 09:00 am ET
Cantel Medical Reports Financial Results For The Third Quarter Ended April 30, 2017
LITTLE FALLS, N.J., June 8, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) reported GAAP net income of $17,511,000, or $0.42 per diluted share, on a 10.6% increase in sales to $192,113,000 for the third quarter ended April 30, 2017. This compares with net income of $14,019,000, or $0.34 per diluted share, on sales of $173,703,000 for the third quarter ended April 30, 2016.
Jun 01, 2017 09:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Third Quarter Ended April 30, 2017
LITTLE FALLS, N.J., June 1, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its third quarter ended April 30, 2017 on Thursday, June 8 before the market opens, and hold a conference call to discuss the results at 11:00 a.m. Eastern Time.
May 25, 2017 09:00 am ET
Cantel Medical to Present at the Jefferies 2017 Global Healthcare Conference
LITTLE FALLS, N.J., May 25, 2017 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the Jefferies 2017 Global Healthcare Conference at the Grand Hyatt in New York City. The formal presentation is scheduled for Friday, June 9, 2017 at 10:00 a.m. EDT. In addition, management will be available for separate one-on-one meetings during the day.
Apr 03, 2017 09:00 am ET
Cantel Medical Completes Acquisition of Select Endoscopy Assets from CR Kennedy in Australia
LITTLE FALLS, N.J., April 3, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today the completion of its acquisition of endoscopy business assets from Australian distributor, CR Kennedy & Company Pty. Ltd.
Mar 22, 2017 01:41 pm ET
Cantel Medical to Present at the 16th Annual Needham & Company Healthcare Conference
LITTLE FALLS, N.J., March 22, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 16th Annual Needham & Company Healthcare Conference at the Westin Grand Central Hotel in New York. The formal presentation is scheduled for Wednesday, April 5, 2017 at 3:00 p.m. ET. In addition, management will be available for separate one-on-one meetings during the day.
Mar 09, 2017 08:00 am ET
Cantel Medical Reports Financial Results For The Second Quarter Ended January 31, 2017
LITTLE FALLS, N.J., March 9, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) reported GAAP net income of $18,070,000, or $0.43 per diluted share, on a 16.8% increase in sales to $184,817,000 for the second quarter ended January 31, 2017. This compares with net income of $15,389,000, or $0.37 per diluted share, on sales of $158,271,000 for the second quarter ended January 31, 2016.
Mar 02, 2017 08:00 am ET
Cantel Medical Corp. to Hold Conference Call to Discuss Results for its Second Quarter Ended January 31, 2017
LITTLE FALLS, N.J., March 2, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) will release the results for its second quarter ended January 31, 2017 on Thursday, March 9 before the market opens, and hold a conference call to discuss the results at 11:00 AM ET.
Feb 16, 2017 03:00 pm ET
Cantel Medical to Expand Direct Sales Operations in Australia
LITTLE FALLS, N.J., Feb. 16, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD), a leading global company dedicated to delivering innovative infection prevention products, services and solutions, announced today that it entered into a definitive agreement to purchase its endoscopy business assets from Australian distributor, CR Kennedy & Company Pty Ltd. The endoscopy business assets consist of Cantel's Medivators®-branded automated endoscope reprocessors, chemistries, procedure room products and other consumables as well as a full sales and service organization.
Jan 03, 2017 09:00 am ET
Cantel Medical Appoints Dottie Donnelly Brienza as Senior Vice President and Chief Human Resources Officer
LITTLE FALLS, N. J., Jan. 3, 2017 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE:CMD) announced today that Dottie Donnelly Brienza has been appointed Senior Vice President and Chief Human Resources Officer, effective January 3, 2017. In this new role, Ms. Brienza will have responsibility for Cantel's global HR function, including its people strategy, policies, systems and processes such as talent management, succession planning, learning and development, compensation and benefits, performance and recruiting. She will serve on the Executive Leadership Team and will report to Cantel's President an
Dec 29, 2016 08:30 am ET
Cantel Medical to Present at the 35th Annual J.P. Morgan Healthcare Conference
LITTLE FALLS, N.J., Dec. 29, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that Jorgen B. Hansen, President and CEO, will be presenting at the 35th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. The formal presentation is scheduled for Wednesday, January 11, 2017 at 4:00 p.m. PT. In addition, management will be available for separate one-on-one meetings during the day.
Dec 08, 2016 08:00 am ET
Cantel Medical Reports Record Results For The First Quarter Ended October 31, 2016
LITTLE FALLS, N.J., Dec. 8, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) reported record US GAAP net income of $18,800,000, or $0.45 per diluted share, on a 22.1% increase in sales to a record $187,725,000 for the first quarter ended October 31, 2016. This compares with net income of $14,254,000, or $0.34 per diluted share, on sales of $153,779,000 for the first quarter ended October 31, 2015.
Oct 14, 2016 11:15 am ET
Cantel Medical Announces 17% Increase In Semiannual Dividend And New Stock Symbol
LITTLE FALLS, N.J., Oct. 14, 2016 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that its Board of Directors approved an increase in its semiannual cash dividend from $0.06 to $0.07 per outstanding share of the Company's Common Stock. The dividend is payable on January 31, 2017 to shareholders of record at the close of business on January 17, 2017.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.